{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T22:23:40Z","timestamp":1773786220631,"version":"3.50.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,27]],"date-time":"2022-04-27T00:00:00Z","timestamp":1651017600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,27]],"date-time":"2022-04-27T00:00:00Z","timestamp":1651017600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Ratchadapiseksompotch Fund, Faculty of Medicine, Chulalongkorn University","award":["RA63\/061"],"award-info":[{"award-number":["RA63\/061"]}]},{"name":"Ratchadapiseksompotch Fund, Faculty of Medicine, Chulalongkorn University","award":["RA63\/061"],"award-info":[{"award-number":["RA63\/061"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The objective of this study was to identify the predictive value for preeclampsia of second-trimester serum high mobility group box-1 (HMGB1) and uterine artery Doppler in singleton pregnancies. Between April 2020 and April 2021, a prospective study was conducted on singleton pregnancies with a gestational age of 16\u201320<jats:sup>+6<\/jats:sup>\u00a0weeks at King Chulalongkorn Memorial Hospital, Department of Obstetrics and Gynecology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand. Maternal characteristics, uterine artery Doppler, and serum HMGB1 were collected. Serum HMGB1 levels and mean uterine artery pulsatility index (UAPI) were combined to calculate the predictive value for preeclampsia. A total of 393 pregnant women were analyzed, with 25 cases (6.4%) developing preeclampsia and 5 cases (1.3%) developing early-onset preeclampsia. Baseline characteristics of preeclampsia and normal pregnant women were comparable. Preeclamptic pregnant women had significantly higher mean serum HMGB1 levels than normal pregnant women (1112.8\u2009\u00b1\u2009363.1\u00a0ng\/mL vs 910.8\u2009\u00b1\u2009486.1\u00a0ng\/mL, p\u2009=\u20090.013). There was no difference in the mean UAPI. Any early-diastolic notching was found more frequently in the preeclampsia group (32.0% vs 12.5%, p\u2009=\u20090.013). The cut-off value for serum HMGB1 levels above 1.04 MoM as abnormal value to predict preeclampsia had sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of 88.0%, 53.5%, 11.4% and 98.5%, respectively. When using abnormal serum HMGB1 levels combined with mean UAPI above 95th percentile, the sensitivity, specificity, PPV and NPV to predict preeclampsia were 88.0%, 50.8%, 10.8% and 98.4%, respectively. This study showed that serum HMGB1 at 16\u201320<jats:sup>+6<\/jats:sup>\u00a0weeks of gestation were effective in predicting preeclampsia. The addition of UAPI did not improve the prediction performance.<\/jats:p>","DOI":"10.1038\/s41598-022-10861-1","type":"journal-article","created":{"date-parts":[[2022,4,27]],"date-time":"2022-04-27T12:04:04Z","timestamp":1651061044000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Second-trimester serum high mobility group box-1 and uterine artery Doppler to predict preeclampsia"],"prefix":"10.1038","volume":"12","author":[{"given":"Varangkana","family":"Wairachpanich","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vorapong","family":"Phupong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,4,27]]},"reference":[{"key":"10861_CR1","doi-asserted-by":"publisher","first-page":"e237","DOI":"10.1097\/AOG.0000000000003891","volume":"135","author":"Gestational Hypertension and Preeclampsia","year":"2020","unstructured":"Gestational Hypertension and Preeclampsia. ACOG practice bulletin, number 222. Obstet. Gynecol. 135, e237\u2013e260 (2020).","journal-title":"Obstet. Gynecol."},{"key":"10861_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejogrb.2013.05.005","volume":"170","author":"E Abalos","year":"2013","unstructured":"Abalos, E., Cuesta, C., Grosso, A. L., Chou, D. & Say, L. Global and regional estimates of preeclampsia and eclampsia: A systematic review. Eur. J. Obstet. Gynecol. Reprod. Biol. 170, 1\u20137 (2013).","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10861_CR3","doi-asserted-by":"publisher","first-page":"E323","DOI":"10.1016\/S2214-109X(14)70227-X","volume":"2","author":"L Say","year":"2014","unstructured":"Say, L. et al. Global causes of maternal death: A WHO systematic analysis. Lancet Glob. Health 2, E323\u2013E333 (2014).","journal-title":"Lancet Glob. Health"},{"key":"10861_CR4","unstructured":"Obstetric and Gynecology Statistical Report. Department of Obstetrics and Gynecology, Faculty of Medicine, Chulalongkorn University; 2014\u20132018 (2018)."},{"key":"10861_CR5","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l2381","volume":"366","author":"GJ Burton","year":"2019","unstructured":"Burton, G. J., Redman, C. W., Roberts, J. M. & Moffett, A. Pre-eclampsia: Pathophysiology and clinical implications. BMJ 366, l2381 (2019).","journal-title":"BMJ"},{"key":"10861_CR6","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1016\/j.placenta.2013.12.008","volume":"35","author":"CW Redman","year":"2014","unstructured":"Redman, C. W., Sargent, I. L. & Staff, A. C. IFPA senior award lecture: Making sense of pre-eclampsia two placental causes of preeclampsia?. Placenta 35, S20\u2013S25 (2014).","journal-title":"Placenta"},{"key":"10861_CR7","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.jri.2010.01.002","volume":"85","author":"S Sharma","year":"2010","unstructured":"Sharma, S., Norris, W. E. & Kalkunte, S. Beyond the threshold: An etiological bridge between hypoxia and immunity in preeclampsia. J. Reprod. Immunol. 85, 112\u2013116 (2010).","journal-title":"J. Reprod. Immunol."},{"key":"10861_CR8","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1111\/j.1600-0897.2012.01120.x","volume":"67","author":"A Fukui","year":"2012","unstructured":"Fukui, A. et al. Changes of NK cells in preeclampsia. Am. J. Reprod. Immunol. 67, 278\u2013286 (2012).","journal-title":"Am. J. Reprod. Immunol."},{"key":"10861_CR9","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.placenta.2012.07.011","volume":"33","author":"TR Everett","year":"2012","unstructured":"Everett, T. R. & Lees, C. C. Beyond the placental bed: Placental and systemic determinants of the uterine artery Doppler waveform. Placenta 33, 893\u2013901 (2012).","journal-title":"Placenta"},{"key":"10861_CR10","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/uog.20105","volume":"53","author":"A Sotiriadis","year":"2019","unstructured":"Sotiriadis, A. et al. ISUOG Practice Guidelines: Role of ultrasound in screening for and follow-up of pre-eclampsia. Ultrasound. Obstet. Gynecol. 53, 7 (2019).","journal-title":"Ultrasound. Obstet. Gynecol."},{"key":"10861_CR11","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1007\/s00404-002-0361-0","volume":"268","author":"V Phupong","year":"2003","unstructured":"Phupong, V. et al. Predicting the risk of preeclampsia and small for gestational age infants by uterine artery Doppler in low-risk women. Arch. Gynecol. Obstet. 268, 158\u2013161 (2003).","journal-title":"Arch. Gynecol. Obstet."},{"key":"10861_CR12","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1080\/jmf.12.2.78.88","volume":"12","author":"AT Papageorghiou","year":"2002","unstructured":"Papageorghiou, A. T., Yu, C. K., Cicero, S., Bower, S. & Nicolaides, K. H. Second-trimester uterine artery Doppler screening in unselected populations: A review. J. Matern. Fetal Neonatal Med. 12, 78\u201388 (2002).","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"10861_CR13","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.cll.2016.01.007","volume":"36","author":"A Rodriguez","year":"2016","unstructured":"Rodriguez, A., Tuuli, M. G. & Odibo, A. O. First-, second-, and third-trimester screening for preeclampsia and intrauterine growth restriction. Clin. Lab. Med. 36, 331 (2016).","journal-title":"Clin. Lab. Med."},{"key":"10861_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-48727-8","volume":"9","author":"N Prakansamut","year":"2019","unstructured":"Prakansamut, N. & Phupong, V. Serum SHARP1 and uterine artery Doppler for the prediction of preeclampsia. Sci. Rep. 9, 1\u20137 (2019).","journal-title":"Sci. Rep."},{"key":"10861_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-021-86073-w","volume":"11","author":"W Tianthong","year":"2021","unstructured":"Tianthong, W. & Phupong, V. Serum hypoxia-inducible factor-1 alpha and uterine artery Doppler ultrasound during the first trimester for prediction of preeclampsia. Sci. Rep. 11, 1\u20137 (2021).","journal-title":"Sci. Rep."},{"key":"10861_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mam.2014.05.001","volume":"40","author":"R Kang","year":"2014","unstructured":"Kang, R. et al. HMGB1 in health and disease. Mol. Aspects Med. 40, 1\u2013116 (2014).","journal-title":"Mol. Aspects Med."},{"key":"10861_CR17","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/j.1600-065X.2007.00574.x","volume":"220","author":"ME Bianchi","year":"2007","unstructured":"Bianchi, M. E. & Manfredi, A. A. High-mobility group box 1 (HMGB1) protein at the crossroads between innate and adaptive immunity. Immunol. Rev. 220, 35\u201346 (2007).","journal-title":"Immunol. Rev."},{"key":"10861_CR18","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1159\/000491390","volume":"55","author":"S Gonelevue","year":"2018","unstructured":"Gonelevue, S., Bandyopadhyay, A., Bhagat, S., Alam, M. I. & Khan, G. A. Sterile inflammatory role of high mobility group box 1 protein: Biological functions and involvement in disease. J. Vasc. Res. 55, 244\u2013254 (2018).","journal-title":"J. Vasc. Res."},{"key":"10861_CR19","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.smim.2018.02.011","volume":"38","author":"U Andersson","year":"2018","unstructured":"Andersson, U., Yang, H. & Harris, H. High-mobility group box 1 protein (HMGB1) operates as an alarmin outside as well as inside cells. Semin. Immunol. 38, 40\u201348 (2018).","journal-title":"Semin. Immunol."},{"key":"10861_CR20","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.placenta.2018.10.011","volume":"72\u201373","author":"LH Tangeras","year":"2018","unstructured":"Tangeras, L. H. et al. Placental inflammation by HMGB1 activation of TLR4 at the syncytium. Placenta 72\u201373, 53\u201361 (2018).","journal-title":"Placenta"},{"key":"10861_CR21","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jri.2011.12.003","volume":"93","author":"K Naruse","year":"2012","unstructured":"Naruse, K. et al. Peripheral RAGE (Receptor for Advanced Glycation Endproducts)-ligands in normal pregnancy and preeclampsia: Novel markers of inflammatory response. J. Reprod. Immunol. 93, 69\u201374 (2012).","journal-title":"J. Reprod. Immunol."},{"key":"10861_CR22","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.placenta.2014.06.370","volume":"35","author":"PA Pradervand","year":"2014","unstructured":"Pradervand, P. A. et al. High mobility group box 1 protein (HMGB-1): A pathogenic role in preeclampsia?. Placenta 35, 784\u2013786 (2014).","journal-title":"Placenta"},{"key":"10861_CR23","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1530\/REP-16-0083","volume":"152","author":"J Shao","year":"2016","unstructured":"Shao, J. et al. Increased levels of HMGB1 in trophoblastic debris may contribute to preeclampsia. Reproduction 152, 775\u2013784 (2016).","journal-title":"Reproduction"},{"key":"10861_CR24","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1161\/ATVBAHA.118.310940","volume":"38","author":"Y Hu","year":"2018","unstructured":"Hu, Y. et al. High-Mobility Group Box 1 from hypoxic trophoblasts promotes endothelial microparticle production and thrombophilia in preeclampsia. Arterioscler. Thromb. Vasc. Biol. 38, 1381\u20131391 (2018).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10861_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0181468","volume":"12","author":"O Erez","year":"2017","unstructured":"Erez, O. et al. The prediction of late-onset preeclampsia: Results from a longitudinal proteomics study. PLoS\u00a0One 12, e0181468 (2017).","journal-title":"PLoS\u00a0One"},{"key":"10861_CR26","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1111\/j.1447-0756.2012.02010.x","volume":"39","author":"A Aksornphusitaphong","year":"2013","unstructured":"Aksornphusitaphong, A. & Phupong, V. Risk factors of early and late onset pre-eclampsia. J. Obstet. Gynaecol. Res. 39, 627\u2013631 (2013).","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"10861_CR27","doi-asserted-by":"publisher","first-page":"e16","DOI":"10.1097\/AOG.0000000000004251","volume":"137","author":"Fetal Growth Restriction","year":"2021","unstructured":"Fetal Growth Restriction. ACOG practice bulletin, number 227. Obstet. Gynecol. 137, e16\u2013e28 (2021).","journal-title":"Obstet. Gynecol."},{"key":"10861_CR28","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1016\/j.placenta.2015.08.006","volume":"36","author":"LL Zhu","year":"2015","unstructured":"Zhu, L. L. et al. HMGB1-RAGE signaling pathway in severe preeclampsia. Placenta 36, 1148\u20131152 (2015).","journal-title":"Placenta"},{"key":"10861_CR29","doi-asserted-by":"publisher","first-page":"5000","DOI":"10.4049\/jimmunol.1303445","volume":"193","author":"RZ Jiang","year":"2014","unstructured":"Jiang, R. Z. et al. Hypoxic trophoblast HMGB1 induces endothelial cell hyperpermeability via the TRL-4\/caveolin-1 pathway. J. Immunol. 193, 5000\u20135012 (2014).","journal-title":"J. Immunol."},{"key":"10861_CR30","doi-asserted-by":"publisher","DOI":"10.1111\/aji.13328","volume":"85","author":"CA Saito Reis","year":"2021","unstructured":"Saito Reis, C. A., Padron, J. G., Norman Ing, N. D. & Kendal-Wright, C. E. High-mobility group box 1 is a driver of inflammation throughout pregnancy. Am. J. Reprod. Immunol. 85, e13328 (2021).","journal-title":"Am. J. Reprod. Immunol."},{"key":"10861_CR31","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/nrrheum.2011.222","volume":"8","author":"HE Harris","year":"2012","unstructured":"Harris, H. E., Andersson, U. & Pisetsky, D. S. HMGB1: A multifunctional alarmin driving autoimmune and inflammatory disease. Nat. Rev. Rheumatol. 8, 195\u2013202 (2012).","journal-title":"Nat. Rev. Rheumatol."},{"key":"10861_CR32","doi-asserted-by":"publisher","first-page":"4570715","DOI":"10.1155\/2017\/4570715","volume":"2017","author":"V Manganelli","year":"2017","unstructured":"Manganelli, V. et al. Elevated serum level of HMGB1 in patients with the antiphospholipid syndrome. J. Immunol. Res. 2017, 4570715 (2017).","journal-title":"J. Immunol. Res."},{"key":"10861_CR33","doi-asserted-by":"publisher","DOI":"10.1111\/aji.13044","volume":"80","author":"KR Heim","year":"2018","unstructured":"Heim, K. R. et al. Excess glucose induce trophoblast inflammation and limit cell migration through HMGB1 activation of Toll-Like receptor 4. Am. J. Reprod. Immunol. 80, e13044 (2018).","journal-title":"Am. J. Reprod. Immunol."},{"key":"10861_CR34","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1002\/uog.5184","volume":"31","author":"F Crispi","year":"2008","unstructured":"Crispi, F. et al. Predictive value of angiogenic factors and uterine artery Doppler for early- versus late-onset pre-eclampsia and intrauterine growth restriction. Ultrasound. Obstet. Gynecol. 31, 303\u2013309 (2008).","journal-title":"Ultrasound. Obstet. Gynecol."},{"key":"10861_CR35","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1002\/ijgo.13302","volume":"151","author":"AS Adefisan","year":"2020","unstructured":"Adefisan, A. S., Akintayo, A. A., Awoleke, J. O., Awolowo, A. T. & Aduloju, O. P. Role of second-trimester uterine artery Doppler indices in the prediction of adverse pregnancy outcomes in a low-risk population. Int. J. Gynecol. Obstet. 151, 209\u2013213 (2020).","journal-title":"Int. J. Gynecol. Obstet."},{"key":"10861_CR36","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1503\/cmaj.070430","volume":"178","author":"JS Cnossen","year":"2008","unstructured":"Cnossen, J. S. et al. Use of uterine artery Doppler ultrasonography to predict pre-eclampsia and intrauterine growth restriction: A systematic review and bivariable meta-analysis. CMAJ 178, 701\u2013711 (2008).","journal-title":"CMAJ"},{"key":"10861_CR37","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1002\/ijgo.13545","volume":"154","author":"SS Dash","year":"2021","unstructured":"Dash, S. S., Jena, P., Khuntia, S., Pathak, M. & Rath, S. K. First- and second-trimester uterine artery pulsatility index as a combination factor in predictive diagnosis of pregnancy-induced hypertension. Int. J. Gynecol. Obstet. 154, 431\u2013435 (2021).","journal-title":"Int. J. Gynecol. Obstet."},{"key":"10861_CR38","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1038\/hr.2014.27","volume":"37","author":"L Kulmala","year":"2014","unstructured":"Kulmala, L. & Phupong, V. Combination of plasma-soluble FMS-like tyrosine kinase 1 and uterine artery Doppler for the prediction of preeclampsia in cases of elderly gravida. Hypertens. Res. 37, 538\u2013542 (2014).","journal-title":"Hypertens. Res."},{"key":"10861_CR39","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/hr.2015.113","volume":"39","author":"P Puttapitakpong","year":"2016","unstructured":"Puttapitakpong, P. & Phupong, V. Combination of serum angiopoietin-2 and uterine artery Doppler for prediction of preeclampsia. Hypertens. Res. 39, 95\u201399 (2016).","journal-title":"Hypertens. Res."},{"key":"10861_CR40","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1001\/jama.2021.14781","volume":"326","author":"US Preventive Services Task Force","year":"2021","unstructured":"US Preventive Services Task Force. Aspirin use to prevent preeclampsia and related morbidity and mortality: US Preventive Services Task Force Recommendation Statement. JAMA 326, 1186\u20131191 (2021).","journal-title":"JAMA"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-10861-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-10861-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-10861-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T01:57:17Z","timestamp":1669341437000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-10861-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,27]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["10861"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-10861-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,27]]},"assertion":[{"value":"22 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6886"}}